Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
The Journal of General Virology
|
May 8, 2020
Human cytomegalovirus major immediate early transcripts arise predominantly from the canonical major immediate early promoter in reactivating progenitor-derived dendritic cells
Rebecca Mason, Ian J Groves, Mark R Wills, et al.
The Journal of Biological Chemistry
|
October 13, 2006
Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter
David L Woodhall, Ian J Groves, Matthew B Reeves, et al.
Journal of Virology
|
June 1, 2012
Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model
Margaret M Huang, Verity G Kew, Kevin Jestice, et al.
Science (New York, N.Y.)
|
June 2, 2007
Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death
Matthew B Reeves, Andrew A Davies, Brian P McSharry, et al.
The Journal of General Virology
|
October 16, 2004
Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo
Matthew B Reeves, Heather Coleman, Jean Chadderton, et al.
The Journal of Infectious Diseases
|
March 6, 2020
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
Cody S Nelson, Ilona Baraniak, Daniele Lilleri, et al.
The Journal of Infection
|
March 23, 2021
Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
Matthew J Murray, Megan McIntosh, Claire Atkinson, et al.
Pathogens (Basel, Switzerland)
|
May 27, 2026
A Potent Inhibitor of Human Cytomegalovirus Infection Works Post-Entry Specifically in Differentiating Myelo-Monocytic Cells
Matthew J Murray, Alexander Hargreaves, Eleanor Bradley, et al.
The Journal of General Virology
|
January 20, 2017
High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification
Amina S Khan, Matthew J Murray, Catherine M K Ho, et al.
Immunology
|
December 7, 2020
IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus
Saima Siddiqui, Sarah Hackl, Hamid Ghoddusi, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
The Journal of General Virology
|
May 8, 2020
Human cytomegalovirus major immediate early transcripts arise predominantly from the canonical major immediate early promoter in reactivating progenitor-derived dendritic cells
Rebecca Mason, Ian J Groves, Mark R Wills, et al.
The Journal of Biological Chemistry
|
October 13, 2006
Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter
David L Woodhall, Ian J Groves, Matthew B Reeves, et al.
Journal of Virology
|
June 1, 2012
Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model
Margaret M Huang, Verity G Kew, Kevin Jestice, et al.
Science (New York, N.Y.)
|
June 2, 2007
Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death
Matthew B Reeves, Andrew A Davies, Brian P McSharry, et al.
The Journal of General Virology
|
October 16, 2004
Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo
Matthew B Reeves, Heather Coleman, Jean Chadderton, et al.
The Journal of Infectious Diseases
|
March 6, 2020
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
Cody S Nelson, Ilona Baraniak, Daniele Lilleri, et al.
The Journal of Infection
|
March 23, 2021
Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
Matthew J Murray, Megan McIntosh, Claire Atkinson, et al.
Pathogens (Basel, Switzerland)
|
May 27, 2026
A Potent Inhibitor of Human Cytomegalovirus Infection Works Post-Entry Specifically in Differentiating Myelo-Monocytic Cells
Matthew J Murray, Alexander Hargreaves, Eleanor Bradley, et al.
The Journal of General Virology
|
January 20, 2017
High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post-translational modification
Amina S Khan, Matthew J Murray, Catherine M K Ho, et al.
Immunology
|
December 7, 2020
IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus
Saima Siddiqui, Sarah Hackl, Hamid Ghoddusi, et al.
Page
of 5